Korro Bio, Inc. Other Nonoperating Expense
Korro Bio, Inc. (KRRO) reported Other Nonoperating Expense of $226.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2022-08-09
- Korro Bio, Inc. other nonoperating expense for the quarter ending 2022-06-30 was $226.00K, a 156.82% increase year-over-year.
- Korro Bio, Inc. other nonoperating expense for the quarter ending 2022-03-31 was $34.00K.
- Korro Bio, Inc. other nonoperating expense for the quarter ending 2021-12-31 was $39.00K.
- Korro Bio, Inc. other nonoperating expense for the quarter ending 2021-09-30 was $139.00K.
- Korro Bio, Inc. other nonoperating expense for fiscal 2021 was $266.00K.
- Korro Bio, Inc. other nonoperating expense for fiscal 2020 was $0.00.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2022-06-30 | $226.00K 10-Q · filed 2022-08-09 | $260.00K 10-Q · filed 2022-08-09 | $299.00K derived: sum of 3 quarters · filed 2022-08-09 | $438.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | $34.00K 10-Q · filed 2022-05-04 | $73.00K derived: sum of 2 quarters · filed 2022-05-04 | $212.00K derived: sum of 3 quarters · filed 2022-05-04 | $300.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $178.00K derived: sum of 2 quarters · filed 2022-03-15 | $266.00K derived: sum of 3 quarters · filed 2022-08-09 | $266.00K 10-K · filed 2022-03-15 |
| 2021-09-30 | $139.00K 10-Q · filed 2021-11-15 | $227.00K derived: sum of 2 quarters · filed 2022-08-09 | $227.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $88.00K 10-Q · filed 2022-08-09 | $88.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |